Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018799 (
heart disease
)
34,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
FG syndrome
was originally described as a rare syndromic cause of X-linked mental retardation associated with congenital
heart disease
, anal atresia, inguinal hernia, cryptorchidism, and other anomalies. However, recent reports have highlighted the more common milder presentation which has for cardinal features developmental delay, particularly in speech, neonatal hypotonia, relative macrocephaly, dysmorphic facial features, severe constipation, and few if any congenital malformations. Thus far, five separate loci have been identified on the X chromosome but attempts at finding the responsible gene have not yet been successful. Given that one putative FG locus (FGS2) is situated at Xq28, which is the location of the Filamin A gene (FLNA), and that a Filamin A mutation was reported in a boy with facial dysmorphism and constipation, it was hypothesized that Filamin A mutations could be one cause of
FG syndrome
. Indeed, a previously unreported FLNA missense mutation (P1291L) was detected in our patient with
FG syndrome
, thus supporting this hypothesis and indicating that
FG syndrome
could now be added to the list of Filamin A-related disorders. Filamin A studies in other children with
FG syndrome
would help to confirm this association.
...
PMID:Filamin A mutation is one cause of FG syndrome. 1763 75